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与胃癌生物学行为的关系，分析 TIPE 对胃癌生长的影响。 
方法：第一部分：（1）利用半定量逆转录-聚合酶链反应（RT-PCR）法检测
46 例胃癌组织及癌旁正常组织中 TIPE mRNA 的表达，并对条带灰度检测分析不
同组织 TIPE mRNA 的表达情况。（2）免疫组化 S-P 法检测胃癌组织及癌旁正常
组织中 TIPE 蛋白的表达，根据 RT-PCR 灰度分析及免疫组化结果，结合临床病
理资料，分析 TIPE 在胃癌发生、发展以及浸润、转移的关系。 
第二部分：（1）我们实验室已构建 TIPE-shRNA-pSIREN-RetroQ 干扰质粒和
pSIREN-RetroQ 阴性对照质粒，利用 shRNA 技术转染 BGC823 细胞干扰 TIPE
蛋白的表达。BGC823 细胞稳定转染 TIPE-shRNA-pSIREN-RetroQ 干扰质粒（干
扰组），BGC823 细胞稳定转染 pSIREN-RetroQ（阴性对照组），正常 BGC823 胃
癌细胞（空白组）。应用蛋白免疫印迹方法（Western blot）和逆转录聚合酶链反
应（RT-PCR）方法鉴定转染效果，（2）应用抗 DR5 单链抗体 aDR5ScFv 刺激后
通过细胞流式术、台盼蓝染色、MTT 实验检测 TIPE 不同表达的 BGC823 细胞的
生长及凋亡情况，Western blot 检测凋亡蛋白 caspase-8、caspase-3、caspase-9 的
活化，进而探讨 TIPE 在胃癌细胞生长中的作用。 

















重及肿瘤大小，治疗两周后摘取肿瘤称重，肿瘤组织经 HE 染色和 TUNEL 染色
分析 TIPE 对胃癌生长的影响，对凋亡诱导剂的敏感性。 
结果：胃癌组织和癌旁正常组织中 TIPE 蛋白均有表达，TIPE mRNA 在胃癌
中的表达明显高于癌旁正常组织（P<0.05），两者差异显著，具有统计学意义，
TIPE mRNA 与胃癌分化程度、淋巴结转移、TNM 相关（P<0.05），与性别、年
龄无关（P>0.05）。 
利用 TIPE 不同表达的胃癌 BGC823 细胞株，经 MTT 检测发现，当 aDR5ScFv










率不同，其中，空白组 19.40%，阴性对照组 17.98%；干扰组 31.68%。以上结果
提示 TIPE 被干扰后提高了 BGC823 细胞对 aDR5ScFv 诱导细胞凋亡的敏感性。
通过蛋白免疫印迹方法（Western blot）发现干扰组 caspase-8、caspase-9和 caspase-3
的活化增强，提示 TIPE 低表达可以通过增强 caspase 活化提高 BGC823 细胞的
凋亡敏感性。 


























低 TIPE 的表达可以增加 BGC823 细胞对 aDR5ScFv 诱导的凋亡敏感性。 





















Background and objects: Gastric cancer is one of the most common cancers 
with serious hazard to human health，accounting for the second most frequent 
malignancy and the third cause of cancer-related death. Now radical surgery is still the 
main treatment and the only mean to cure gastric cancer. But most gastric cancer 
patients are usually diagnosed in the later stages of the disease in clinical and has very 
poor prognosis due to patients with unresectable therapeutic options. Therefore, there 
is clinical significance to extensively investigate the molecular mechanisms of gastric 
carcinogenesis, to Provide the basis for the early diagnosis of gastric cancer, and also 
provide an effective target in the treatment of clinical treatment ,Tumor necrosis 
factor-α induced protein 8(TIPE) is a recently discovered antiapoptotic 
molecule．Recent data have demonstrated that TIPE is involved in the regulation of 
apoptosis, cellular signaling cascade andtumor proliferation，invasion as well as 
metastasis, This study through at a cellular level and molecular level TIPE protein and 
mRNA expression in gastric cancer tissue, to analyze their relationship with clinical 
pathological characteristics of gastric cancer, to explore TIPE's relationship with 
gastric cancer biological behavior. 
Method: Part 1(1) RT-PCR method were used to detect of 46 cases of gastric 
cancer tissue and normal adjacent tissue of TIPE mRNA expression, Analysis of gray 
distribution TIPE mRNA expression in different tissue. (2) Using RT-PCR gray 
distribution results to detect the TIPE protein expression in gastric cancer tissue and 
normal adjacent tissue by immunohistochemical SP method. According to the clinical 
pathological data, analysis TIPE in gastric cancer occurrence, development and the 
relationship of invasion and metastasis. 
Part 2 (1) The TIPE shRNA was chemical synthesized and transfected into 
BGC823 cells with lipofectamine 2000. The expression of TIPE mRNA was detected 
by using RT-PCR; the expression of TIPE protein was detected by using Western Blot. 
(2)AdoptedaDR5ScFv stimulate, using Western Blotmethoddetect aspartate-specific 
cysteineproteolysisenzyme (caspase) expression; the cellular mortality was examined 
















and Flowcytometry.  
Part 3We have been transplanted nude mice to constructed model.Treatment and 
measurement of body weight of mice and tumor size after treated with aDR5ScFv 
100ul (1.62mg/ml) every day, after two weeks of treatment for nude mice tumor. HE 
and TUNEL staining assay for the tumor tissue were performed to detect apoptosis. In 
vitro experiments, the measurement of body weight of nude mice and tumor size and 
weight after two weeks of treatment for nude mouse tumor.  
Result: Part 1 We found that the TIPE mRNA and protein was expressed in 
gastric cancer tissue also in adjacent tissue, it was clearly localized in the cytoplasmic 
compartment of the tumor cells, our test shows that TIPE mRNA in gastric cancer 
tissue expression were higher than in adjacent tissues, the differences was significant 
(P<0.05). In analysis, high TIPE expression was found to be a significant in addition 
to tumor depth and differentiation, the presence of lymph node metastasis, distant 
metastasis(P<0.05).  
Part 2 After transfected BGC823 human gastric cancer cell lines, we found that 
caspase-8, caspase-9 and caspase-3 expressed significantly difference before and after 
transfection, MTT results showed the cytotoxic effect of aDR5ScFv to cancer cells 
were dose dependent. Flow cytometer tested 100μg/ml aDR5ScFv induced apoptosis 
of cells for 24 hours, TIPE shRNA: 31.68%; the blank group: 19.40%; the negative 
group: 17.98%. Trepan blue staining results show that the TIPE shRNA group cells 
obviously higher mortality.  
Part 3 Observed in vivo experiments to TIPE shRNA transfectants compar
ed with the untransfectants, tumors (0.019 ± 0.004g. 232.586 ± 31.632 mm3) o
f TIPE shRNA transfectants were significantly smaller than tumors of untransfe
ctants (0.026±0.003g, 252.825±34.883mm3, P<0.05).Tumors (0.008±0.002g, 94.9
87±24.287mm3) of TIPE shRNA transfectants treated with aDR5ScFv were sma
ller than tumors (0.016±0.003g, 178.387±8.083mm3, P<0.05) treated by saline. 
 The weight of mice was not significantly different between the aDR5ScFv an
d saline groups (P>0.05). Furthermore, the mice were in good condition and h
ad active behavior throughout the study, suggesting that aDR5ScFv administrati
on had no obvious side effects. TIPE shRNA promotes more tumor cell death 
in vivo after hematoxylin-eosin staining, than tumor tissue from nude mice inje
cted with aDR5ScFv, disappearance of intracellular structures, and cell sputterin
















d the expected large and irregular cell shapes, the BGC823 tumor also injected
 aDR5ScFv, the death degree between them. inversion in the ratio of nucleopla
sm to cytoplasm volume, and mitotic pathologies. These findings were supporte
d by TUNEL staining, which provided semi-quantitative information about apop
tosis levels. In the TUNEL assay, apoptotic cells are green and they show a c
ondensed nucleus and cytoplasm as well as irregular cell shape, healthy cells, i
n contrast, show normal morphology and weak or no green staining. 
Conclusion: It was found that the mRNA and protein level of TIPE expression 
higher in gastric cancer tumor tissue, shRNA interference of TIPE obviously 
down-regulates the Molecule at mRNA and protein levels in BGC823 cells, and 
results in significant inhibition in the effort proliferation and apoptosis of the cells. 
Therefore, TIPE gene in gastric cancer treatment may become a new target. 
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